Jialin Luo

Jialin Luo

Auto-generated profile, based on publicly available information

Jialin Luo

Department of Radiation Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
YFYanru Feng
Yanru Feng
JLJialin Luo
Jialin Luo
PLPeng Liu
Peng Liu
LLLuying Liu
Luying Liu
YZYuan Zhu
Yuan Zhu
LZLinfeng Zheng
Linfeng Zheng
Feng Y, et al. Ann Surg Treat Res. 2022 Mar;102(3):153-158. https://doi.org/10.4174/astr.2022.102.3.153

14 February 2022 in Discover Oncology
Verified
Journal Article
Open access
PDF file
YFYanru Feng
Yanru Feng
JLJialin Luo
Jialin Luo
PLPeng Liu
Peng Liu
YZYuan Zhu
Yuan Zhu
GCGuoping Cheng
Guoping Cheng
LLLuying Liu
Luying Liu
Purpose: To evaluate the role of programmed death-ligand 1 (PD-L1) and mammalian target of rapamycin (mTOR) signaling pathway in locally advanced rectal cancer (LARC).Methods: Between February 2012 and February 2018, 103 patients with LARC treated by neoadjuvant chemoradiotherapy (neoCRT) and total mesorectal excision (TME) were included. PD-L1, mTOR and p-mTOR of pair-matched pre-neoCRT biopsies and post-neoCRT surgical tissue were evaluated by immunohistochemistry.Results: The mean combined positive score (CPS), tumor proportion score (TPS) and immune cell score (IC) of pre-neoCRT were 2.24 (0–70), 1.87 (0–70) and 0.67 (0–10), respectively. The mean CPS, TPS and IC of post-neoCRT were 2.19 (0–80), 1.38 (0–80) and 1.60 (0–20), respectively. Significant difference was observed in terms of IC between pre-neoCRT and post-neoCRT (p = 0.010). The 5-year disease-free survival (DFS) rate of the whole group was 62.4%. Multivariate analysis by Cox model indicated that pre-neoCRT TPS [hazard ratio (HR) 1.052, 95% confidence interval (CI) 1.020–1.086, p = 0.001] and post-neoCRT CPS (HR 0.733, 95% CI 0.555–0.967, p = 0.028) were associated with DFS. In the 89 patients without pathological complete response, p-mTOR and IC were upregulated after neoCRT.Conclusions: For patients with LARC treated by neoCRT and TME, p-mTOR and IC were upregulated after neoCRT. Pre-neoCRT TPS and post-neoCRT CPS were independent prognostic predictors of DFS.